These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12569567)

  • 1. Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase.
    Meyer T; Xu L; Chang J; Liu ET; Craven RJ; Cance WG
    Int J Cancer; 2003 Mar; 104(2):139-46. PubMed ID: 12569567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.
    Cance WG; Craven RJ; Bergman M; Xu L; Alitalo K; Liu ET
    Cell Growth Differ; 1994 Dec; 5(12):1347-55. PubMed ID: 7696183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear tyrosine kinase Rak associates with the retinoblastoma protein pRb.
    Craven RJ; Cance WG; Liu ET
    Cancer Res; 1995 Sep; 55(18):3969-72. PubMed ID: 7664264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor.
    Jin L; Craven RJ
    Oncogene; 2014 Jan; 33(3):326-35. PubMed ID: 23318459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Rak tyrosine kinase function in breast cancer.
    Yim EK; Siwko S; Lin SY
    Cell Cycle; 2009 Aug; 8(15):2360-4. PubMed ID: 19597351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical versus molecular detection of RAK antigens in breast cancer.
    Kyriacou KC; Iacovou F; Adamou A; Hadjisavvas A; Rakowicz-Szulczynska EM
    Exp Mol Pathol; 2000 Aug; 69(1):27-36. PubMed ID: 10891290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity.
    Welsh M; Welsh C; Ekman M; Dixelius J; Hägerkvist R; Annerén C; Akerblom B; Mahboobi S; Chandrasekharan S; Liu ET
    Biochem J; 2004 Aug; 382(Pt 1):261-8. PubMed ID: 15186217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
    Goel RK; Lukong KE
    Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
    Yim EK; Peng G; Dai H; Hu R; Li K; Lu Y; Mills GB; Meric-Bernstam F; Hennessy BT; Craven RJ; Lin SY
    Cancer Cell; 2009 Apr; 15(4):304-14. PubMed ID: 19345329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1.
    Goel RK; Miah S; Black K; Kalra N; Dai C; Lukong KE
    FEBS J; 2013 Sep; 280(18):4539-59. PubMed ID: 23822091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent.
    Chen X; Lowe M; Keyomarsi K
    Oncogene; 1999 Oct; 18(41):5691-702. PubMed ID: 10577141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New protein and PCR markers RAK for diagnosis, prognosis and surgery guidance for breast cancer.
    Rakowicz-Szulczynska EM; Markowski M; Mackiewicz A; Karczewska A; Snyder W; McIntosh DG; Kapcinska M; Smith ML
    Cancer Lett; 1997 Jan; 112(1):93-101. PubMed ID: 9029174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
    Zagozdzon R; Bougeret C; Fu Y; Avraham HK
    Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRK tyrosine kinase expression in a high proportion of human breast carcinomas.
    Barker KT; Jackson LE; Crompton MR
    Oncogene; 1997 Aug; 15(7):799-805. PubMed ID: 9266966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y
    J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.